Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Immunological, Dermatological, and Neurological Effects of Sirolimus in Ataxia-Telangiectasia

NCT07820579 is registered in ClinicalTrials.gov with Sara Elva Espinosa Padilla, MD as lead sponsor.

NCT NCT07820579
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07820579 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Immunological, Dermatological, and Neurological Effects of Sirolimus in Ataxia-Telangiectasia
Lead sponsor
Sara Elva Espinosa Padilla, MD
Phase
Phase 2
Overall status
Completed
Start date
July 11, 2024
Completion date
August 20, 2026
Enrollment
6 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ataxia-telangiectasia, ataxia-telangiectasia (a-t)